This article reviews how the molecular evolution of GLP-1 and GLP1R contributes to the selective interaction between this ligand-receptor pair, providing critical clues for the development of potent agonists for the treatment of diabetes mellitus and obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.